Multiple Assemblies exist for SMTL entry 4kio
Kinase domain mutant of human Itk in complex with a covalently-binding inhibitor; X-RAY DIFFRACTION 2.18 Å

	SMTL ID 4kio.1 Ligands 1-[(3S)-3-{[4-(morpholin-4-ylmethyl)-6-([1,3]thiazolo[5,4-b]pyridin-2-ylamino)pyrimidin-2-yl]amino}pyrrolidin-1-yl]prop-2-en-1-one Polypeptides Tyrosine-protein kinase ITK/TSK Oligo-state monomer
	SMTL ID 4kio.2 Ligands 1-[(3S)-3-{[4-(morpholin-4-ylmethyl)-6-([1,3]thiazolo[5,4-b]pyridin-2-ylamino)pyrimidin-2-yl]amino}pyrrolidin-1-yl]prop-2-en-1-one Polypeptides Tyrosine-protein kinase ITK/TSK Oligo-state monomer
	SMTL ID 4kio.3 Ligands 1-[(3S)-3-{[4-(morpholin-4-ylmethyl)-6-([1,3]thiazolo[5,4-b]pyridin-2-ylamino)pyrimidin-2-yl]amino}pyrrolidin-1-yl]propan-1-one; 1-[(3S)-3-{[4-(morpholin-4-ylmethyl)-6-([1,3]thiazolo[5,4-b]pyridin-2-ylamino)pyrimidin-2-yl]amino}pyrrolidin-1-yl]prop-2-en-1-one; SULFATE ION; GLYCEROL Polypeptides Tyrosine-protein kinase ITK/TSK Oligo-state monomer
	SMTL ID 4kio.4 Ligands 1-[(3S)-3-{[4-(morpholin-4-ylmethyl)-6-([1,3]thiazolo[5,4-b]pyridin-2-ylamino)pyrimidin-2-yl]amino}pyrrolidin-1-yl]propan-1-one; SULFATE ION Polypeptides Tyrosine-protein kinase ITK/TSK Oligo-state monomer